Searched for
ASTRAZENECA PHARMA SHARES
AstraZeneca Pharma surges 10% as WHO gives nod to Covid vaccine for emergency useThe WHO said on Monday that it was clearing the AstraZeneca vaccines made by the Serum Institute of India and South Korea's AstraZeneca-SKB...16 Feb, 2021, 09.51 AM IST- AstraZeneca Pharma gets DCGI nod to market asthma drugAstraZeneca Pharma said the receipt of this permission paves way for the launch of Benralizumab (Fasenra) in India, subject to the receipt ...21 Dec, 2020, 11.47 AM IST
- AstraZeneca Pharma India gets DCGI nod to market diabetes drugThe product is indicated as an adjunct therapy to diet and exercise to improve glycemic control in adults with type 2 diabetes, AstraZeneca...17 Oct, 2017, 06.01 PM IST
- AstraZeneca Pharma India appoints Gagan Singh Bedi as MDThe company has accepted resignation of Sanjay Murdeshwar as MD and as a director. He is shifting to a global role within the AstraZeneca g...29 Jun, 2017, 07.33 PM IST
- AstraZeneca Pharma India to close Bengaluru API unitDrug firm AstraZeneca Pharma India will close its Active Pharmaceutical Ingredient (API) unit at Bengaluru due to low demand for the produc...03 Dec, 2015, 05.51 PM IST
- AstraZeneca Pharma board approves delisting of company's shares from stock exchangesAstraZeneca Pharma today said its board has approved delisting of the company's shares from bourses, including BSE and the National Stock E...18 Mar, 2014, 10.44 PM IST
- AstraZeneca Pharma shares rise 3 per cent on board's approved delisitngShares of AstraZeneca Pharma rose by 3 per cent as its board has approved delisting of the company's shares from bourses like NSE, BSE etc.18 Mar, 2014, 06.08 PM IST
- Buy AstraZeneca Pharma Ltd with target price of Rs 1020: Sandeep WagleAstraZeneca Pharma Ltd is a 'BUY' call with a target of Rs 1020 and a stop loss of Rs 884.03 Mar, 2014, 11.23 AM IST
- AstraZeneca up 20% on delisting proposal, locked in upper circuit at Rs 1,110.90AstraZeneca said in the filing before markets opened on Monday that its board received a request from its promoter to initiate a voluntary ...03 Mar, 2014, 11.22 AM IST
- Buy AstraZeneca Pharma India Ltd with a target of Rs 870: Ashwani Gujral"AstraZeneca Pharma India Ltd is a ‘BUY’ call with a target of Rs 870 and a stop loss of Rs 825."27 Aug, 2013, 08.45 AM IST
- Buy AstraZeneca Pharma with target price of Rs 930: Ashwani GujralAstraZeneca Pharma Ltd is a 'BUY' call with a target of Rs 930 and a stop loss of Rs 850.16 Aug, 2013, 09.51 AM IST
- AstraZeneca Pharma promoter to sell stake in Indian armAstraZeneca India today said its promoter AstraZeneca Pharmaceuticals AB Sweden plans to offload around 37 lakh shares through offer for sa...24 May, 2013, 07.56 PM IST
- AstraZeneca to receive over Rs 140 crore grant from promoterAstraZeneca Pharma AB would be provide the first tranche of Rs 74 cr to the Indian firm in the current financial year, it added.06 May, 2013, 04.23 PM IST
- Buy AstraZeneca Pharma with a target of 1860: Sandeep WagleAstraZeneca Pharma India Ltd is a ‘BUY’ call with a target of Rs 1860 and a stop loss of Rs 1680.22 Aug, 2012, 10.07 AM IST
- AstraZeneca Q4 net loss at Rs 33 crAstraZeneca Pharma India today reported a net loss of Rs 33 crore for the quarter ended March 31, 2012, due to a voluntary recall of steril...12 May, 2012, 04.40 PM IST
- AstraZeneca planning to delist Indian subsidiary; likely to appoint Merrill Lynch as manager for delistingAstraZeneca, the world's seventh largest drug maker by sales, is planning to delist its Indian subsidiary, said two people with knowledge o...06 Mar, 2012, 06.02 AM IST
- AstraZeneca Pharma to delist from India; shares jump 20 pcAstraZeneca Pharma India today said it will de-list itself from domestic stock exchanges, fueling a jump of 20 per cent in its stock price ...29 Jun, 2010, 02.27 PM IST
Load More
